The vendor required to provide case management, re-entry planning, cognitive behavioral and medications for opioid use disorder (MOUD) services (prescribing and clinical and medical oversight) for individuals incarcerated in county jails.
- Identify and assess current jail organizational context
• Existing policies
• Capability of the workforce
• Capacity of the workforce
• Financing and resources
• Prevailing culture
• Organizational priorities
• Leadership commitment and priorities
• Determine which program model is best for the facility
- Identify program capacity: several metrics will need to be identified and assessed, including, but not limited to:
• Individuals entering the facility are currently enrolled in a community-based OTP.
• Individuals entering the facility are currently prescribed buprenorphine or methadone.
• Individuals enter the facility in opioid withdrawal or demonstrating other signs of oud who are not currently enrolled in an OTP or prescribed buprenorphine or methadone
- Early assessment
• Responsible for completing a behavioral health biopsychosocial assessment on inmates within two (2) working days of referral.
• Validated screening and diagnostic tools for oud and provide justification for tools selected.
- During incarceration work with jail staff to:
• Offer or initiation of MOUD to individuals with oud not already identified and offered treatment at intake (e.g., individuals with oud but without physical dependence).
• Educate individuals on treatment choices and the process for continuation of access to MOUD, during incarceration, and upon release.
• Administer methadone and buprenorphine daily or more frequently.
• Contractor(s) will not use alternate-day (balloon) dosing of buprenorphine.
• Offer counseling for all individuals qualifying for MOUD and consenting to counseling, regardless of length of stay.
• Provide MOUD not contingent on the individual’s willingness to participate in counseling.
- Treatment planning
• Determine which medications are offered.
• Medication first or “low-threshold” models prioritize providing access to evidence- based medications for oud as quickly as possible, without restrictions or ancillary requirements, while also honoring patients’ choices related to treatment.
• Determine what medications are available in the community.
• Development of dosage guidelines.
• Establish screening protocols to determine eligibility.
• Develop guidelines for ongoing care.
• Develop protocols related to drug testing.
• Develop protocols for pregnant women and individuals with co-occurring disorders.
• Develop protocols for discharge and release.
- Case management services
• The intensive case management approach promotes independence and pro-social behavior through assessment, the identification and coordination of appropriate services and on-going support, as needed by the client.
• The development of a supportive relationship between the case manager and the client is an essential component of this process.
• A key element of in-custody case management is the development and use of the case plan.
• This plan is developed with each client based on assessment results, is updated as needed, and follows the individual into the community to probation or any other service provider.
• The case plan is a collaborative product involving the case manager, the client, and partner agencies who may be involved in the client’s life.
• The case plan describes (for those with longer in-custody stays) the needs, goals, and objectives of the client’s in-custody treatment episode, as well as, the interventions and services they will receive while in-custody.
• The plan must provide a coordinated approach designed to include re-entry planning (screening and assessment of barriers to reintegration), and coordination of continued care that will be needed to break the cycle of repeated criminal behavior.
• Case managers will be expected to follow clients from assessment to release and follow up to ensure clients have connected to the referred resources in the community.
- Contract Period/Term: 1 year
- Questions/Inquires Deadline: January 29, 2026
